Lian Liu

机构：Shenzhen University Health Science Center

发表论文 136 篇 · 总被引 3202 次 · h-index 26

代表论文

• Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial (2025 · Nature Medicine · 被引 30)
• Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials (2025 · 癌症：英文版 · 被引 12)
• Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial (2025 · The Lancet Respiratory Medicine · 被引 10)
• Bioactive ROS-responsive nanotherapeutics attenuate intermittent hypoxia-induced cognitive impairment via NRF2/KEAP1/HO-1 signaling (2025 · Neurochemistry International · 被引 6)
• The Lattice flow diverter for the treatment of intracranial aneurysms: a single center experience in 117 consecutive aneurysms (2025 · Journal of NeuroInterventional Surgery · 被引 4)
• Reduced exosomal miR-215-5p activates the NEAT1/MAPK1/p-CRMP2 pathway and contributes to social dysfunction in a VPA-induced autism model (2025 · Neuropharmacology · 被引 4)